- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.57 Å
- Oligo State
- monomer
- Ligands
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 1 x XV3: (2E)-1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(4R,7aS)-2-methylidenetetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}-3-{4-[(dimethylamino)methyl]-5-methylpyridin-2-yl}prop-2-en-1-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nilewski, C. et al., Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors. Acs Med.Chem.Lett. (2024)
- Release Date
- 2023-12-20
- Peptides
- GTPase KRas: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A